Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gerard Lozanski

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Blood

English

TCL1targetingmiR-3676is Codeleted With Tumor Protein P53 in Chronic Lymphocytic Leukemia

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2015

English

A Novel Regimen for Relapsed/Refractory Adult Acute Myeloid Leukemia Using a KMT2A Partial Tandem Duplication Targeted Therapy: Results of Phase 1 Study NCI 8485

Haematologica

Hematology

2018

English

Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

American Journal of Hematology

Hematology

2015

English

Improved Efficacy Using Rituximab and Brief Duration, High Intensity Chemotherapy With Filgrastim Support for Burkitt or Aggressive Lymphomas: Cancer and Leukemia Group B Study 10 002

British Journal of Haematology

Hematology

2014

English

Granulocyte Colony-Stimulating Factor–Mobilized Allografts Contain Activated Immune Cell Subsets Associated With Risk of Acute and Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Erratum to “Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated With Risk of Acute and Chronic Graft-Versus-Host Disease” [Biol Blood Marrow Transplant 22(2016):658-668]

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

Computer-Assisted Quantification of CD3+ T Cells in Follicular Lymphoma

English

Resistance to the Translation Initiation Inhibitor Silvestrol Is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells

AAPS Journal

Pharmaceutical Science

2011

English

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997

Leukemia and Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Gerard Lozanski

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

TCL1targetingmiR-3676is Codeleted With Tumor Protein P53 in Chronic Lymphocytic Leukemia

A Novel Regimen for Relapsed/Refractory Adult Acute Myeloid Leukemia Using a KMT2A Partial Tandem Duplication Targeted Therapy: Results of Phase 1 Study NCI 8485

Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

Improved Efficacy Using Rituximab and Brief Duration, High Intensity Chemotherapy With Filgrastim Support for Burkitt or Aggressive Lymphomas: Cancer and Leukemia Group B Study 10 002

Granulocyte Colony-Stimulating Factor–Mobilized Allografts Contain Activated Immune Cell Subsets Associated With Risk of Acute and Chronic Graft-Versus-Host Disease

Erratum to “Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated With Risk of Acute and Chronic Graft-Versus-Host Disease” [Biol Blood Marrow Transplant 22(2016):658-668]

Computer-Assisted Quantification of CD3+ T Cells in Follicular Lymphoma

Resistance to the Translation Initiation Inhibitor Silvestrol Is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997